HEPA, PM2.5, and Cardiometabolic Health
University of Southern California · with Duke University · NCT05718245
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65–84 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 52
- US sites recruiting
- 1
- Study start
- March 15, 2023
- Record last updated
- August 1, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
Being studied: HEPA filter; Sham filter
Conditions: Air Pollution; Cardiometabolic Health
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age between 65 and 84 years old;
- Nonsmoker for at least 1 year;
- History of BMI ≥ 25 kg/m2 in the past based on EMR information;
- Either an English or Spanish speaker;
- Live in the Los Angeles County.
Exclusion Criteria
- History of diabetes (both type 1 and type 2) or degenerative disease of the nervous system (Alzheimer's disease or dementia);
- Currently have active cancer treatment;
- The residential house has already had HEPA filters;
- Participants will move out of the current house in the next 2 years;
- Participants will spend more than one month living outside the primary home;
- Have any health conditions that prohibit collecting health and covariate data and biospecimen;
- The residential houses are not feasible for setting up air purifiers and air pollutants monitors;
- Have high blood glucose from finger stick test (> 200 mg/dL).
Recruiting US locations
Keck School of Medicine, University of Southern California
Los Angeles, CA 90033
Site contact: Zhanghua Chen, PhD · 323-442-2109 · zhanghuc@usc.edu
Study contacts (from the official record)
- Zhanghua Chen, PhD · 323-442-2109 · zhanghuc@usc.edu
- Junfeng Zhang, PhD · 919-681-7782 · junfeng.zhang@duke.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55